Mineralys prices $150M public offering of 5.66M shares at $26.50, diluting existing holders

Filed June 3, 2026 · Period ending June 3, 2026 · ~1 min read

Key Changes

• high

  Company sold 5.66 million shares at $26.50 each in a public offering, expecting net proceeds of $142.5M after underwriting fees and expenses. This represents immediate dilution of approximately 10-15% to existing shareholders.

  Item 1.01 view on EDGAR →
• medium

  Underwriters (BofA Securities, Goldman Sachs, Evercore) purchased shares at $25.31, representing a $1.19 per share discount. The 4.5% underwriting spread is standard for biotech offerings of this size.

  Item 1.01 view on EDGAR →
• medium

  Offering expected to close June 4, 2026, one day after pricing. The rapid timeline suggests strong institutional demand and allows the company to access capital quickly.

  Item 1.01 view on EDGAR →